STOCK TITAN

RenX Enterprises (NASDAQ: RENX) cuts $7.2M debt, wins approval for massive share issuances

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

RenX Enterprises Corp. entered into a related-party debt-for-equity exchange, cancelling $7,169,072.79 of promissory note debt in return for 7,169 shares of new Series C Convertible Preferred Stock and a warrant for 619,084 common shares. The preferred initially converts at $2.895 per share into 2,476,338.51 common shares, with an 8% dividend (increasing to 9% if not paid in cash), a 150% liquidation preference, and redemption premia up to 115% of stated value. If fully converted at the floor price of $1.50, the preferred could yield up to 4,779,333 common shares, subject to Nasdaq-driven stockholder caps and 4.99%–19.99% beneficial ownership limits. Stockholders also approved large potential issuances tied to prior financings, including up to 26,779,029 shares from April Notes and up to 179,213,485 shares from Additional April Notes, a 1-for-5 to 1-for-10 reverse split authorization, and an increase in 2023 plan share reserves to 520,000 shares.

Positive

  • Elimination of related-party debt: RenX cancelled $7,169,072.79 of insider-held promissory note debt by exchanging it for Series C Convertible Preferred Stock and warrants, reducing leverage and cash interest without using cash proceeds.

Negative

  • Extraordinary authorized share overhang: Stockholders approved issuance of up to 26,779,029 shares from April Notes and up to 179,213,485 shares from Additional April Notes, versus 2,499,293 common shares outstanding as of the record date, implying very large potential dilution.

Insights

RenX swaps insider debt for preferred equity but adds very large potential dilution.

RenX cancelled $7.17M of related-party debt by issuing Series C Convertible Preferred Stock and warrants, removing that obligation from the balance sheet and reducing cash interest. The preferred carries an 8%–9% dividend, 150% liquidation preference, and redemption premia up to 115% of stated value.

The conversion terms are aggressive. At the initial price of $2.895 per share, the preferred equates to 2,476,338.51 common shares, and if reset to the $1.50 floor could reach 4,779,333 shares, plus 619,084 warrant shares. Separately, stockholders authorized up to 26,779,029 shares from April Notes and 179,213,485 shares from Additional April Notes, versus 2,499,293 shares outstanding as of the record date.

Beneficial Ownership Limitations of 4.99%–19.99%, an exchange cap tied to Nasdaq rules, and the possibility to re-exchange preferred into a 10% unsecured note upon a prolonged Nasdaq delisting add structural protections and contingencies. However, the authorized share levels for note conversions and equity plans point to a highly equity-dependent funding model with substantial dilution potential if fully utilized.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Debt exchanged $7,169,072.79 Principal and accrued interest cancelled under Amended and Restated Promissory Note
Series C Preferred issued 7,169 shares Issued June 11, 2026 in exchange for Outstanding Debt
Initial conversion price $2.895 per share Series C Preferred conversion into common stock
Max conversion at floor 4,779,333 shares Common shares if Series C converts at $1.50 floor price
Warrant coverage 619,084 shares at $2.895 Common stock purchasable under new warrant, 5-year term
April Notes conversion approval 26,779,029 shares Common shares issuable from up to $13.0M April Notes at floor terms
Additional April Notes approval 179,213,485 shares Common shares issuable from up to $87.0M Additional April Notes at floor terms
Shares outstanding 2,499,293 shares Common stock outstanding as of April 13, 2026 record date
Series C Convertible Preferred Stock financial
"7,169 shares (the “Preferred Shares”) of a newly designated series of Series C Convertible Preferred Stock"
Series C convertible preferred stock is a class of investment shares issued in a later private financing round that combine safety and upside: they usually pay ahead of ordinary shares if a company pays dividends or is sold, but can be converted into common stock to share in future growth. For investors this acts like a VIP ticket with a safety net—offering priority protection while preserving the option to participate in a successful exit.
full-ratchet style adjustment financial
"The conversion price is also subject to the full-ratchet style adjustment for dilutive issuances"
Beneficial Ownership Limitation financial
"A holder of the Preferred Stock is prohibited from converting ... (the “Beneficial Ownership Limitation”)"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Fundamental Transaction financial
"upon occurrence of a Fundamental Transaction (as such term is defined in the Certificate of Designation)"
Section 3(a)(9) regulatory
"relied upon the exemption from the registration requirements ... available under Section 3(a)(9)"
Section 3(a)(9) is a provision of U.S. securities law that exempts certain exchanges of an issuer’s own securities with its existing holders from the usual public registration rules, typically when the swap doesn’t involve a public offering or outside buyers. For investors, it matters because such exchanges can change who holds what, affect dilution and liquidity, and may occur with less public disclosure than a registered sale — think of it like swapping old coupons for new ones behind the scenes rather than selling them in a public marketplace.
Nasdaq Rule 5635(d) regulatory
"The stockholders approved, pursuant to Nasdaq Rule 5635(d), the issuance of up to 862,335 shares"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false --12-31 0001959023 0001959023 2026-06-10 2026-06-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 10, 2026

 

RENX ENTERPRISES CORP.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-41581   87-1375590
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification Number)

 

1111 Brickell Ave, Floor 11 Suite 109

Miami FL 33131

(Address of Principal Executive Offices, Zip Code)

 

 

(Former name or former address, if changed since last report.)

 

Registrant’s telephone number, including area code: (786) 808-5776

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
Common Stock, par value $0.001‌   RENX   The Nasdaq Stock Market LLC‌

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement

 

On June 11, 2026, RenX Enterprises Corp. (the “Company”) entered into an exchange agreement (the “Exchange Agreement”) with Index Equity US, LLC, a related party (the “Debtholder”), to exchange (the “Exchange”) $7,169,072.79 of principal and accrued interest outstanding (the “Outstanding Debt”) under an Amended and Restated Promissory Note, dated January 1, 2025 (originally issued by the Company to MCS Lending, LLC (a related party) and assigned to Debtholder on June 9, 2026) (the “Note”), for 7,169 shares (the “Preferred Shares”) of a newly designated series of Series C Convertible Preferred Stock (the “Preferred Stock”), convertible at an initial conversion price of $2.895 per share into 2,476,338.51 shares of common stock (the “Conversion Shares”) and a common stock purchase warrant (the “Warrant” and, together with the Preferred Shares, the “Securities”) to purchase up to 619,084 shares of the Company’s common stock (the “Common Stock”) exercisable at an initial exercise price of $2.895 per share, subject to, among other things, adjustment, shareholder approval (if required under Nasdaq rules) and certain beneficial ownership limitations. Pursuant to the Exchange Agreement, on June 11, 2026, the Company issued the Securities and the Outstanding Debt was cancelled.

 

Bjarne Borg, our director, is the manager of Index Equity US, LLC, the Debtholder.

 

The Preferred Stock

 

Certificate of Designation

 

The terms of the Preferred Stock are set forth in the Certificate of Designation for the Preferred Stock (the “Certificate of Designation”). On June 10, 2026, the Company filed the Certificate of Designation with the Delaware Secretary of State which sets forth the following key terms:

 

Par Value/Stated Value

 

The Preferred Stock has $0.001 par value and a stated value equal to $1,000.00.

 

Conversion Terms

 

Each share of Preferred Stock is initially convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, at $2.895 per share.

 

The conversion price is subject to standard proportional adjustment for stock dividends, stock splits or similar events, subject to a floor price of $1.50 (the “Floor Price”). The conversion price is also subject to the full-ratchet style adjustment for dilutive issuances (each a, “Dilutive Issuance”), subject to the Floor Price and with Exempt Issuances (as defined in the Certificate of Designations) carved out. If a holder elects to convert following a Dilutive Issuance that causes the conversion price to be less than the Floor Price, then the holder would receive the Conversion Shares based upon the Floor Price plus a cash true-up. The issuance of all of the Conversion Shares issuable upon conversion of the Preferred Stock, including, without limitation, to give full effect to any adjustment to the conversion price following any stock dividend, stock split or other share combination event or a Dilutive Issuance is subject to Company stockholder approval, to the extent required by the applicable rules and regulations of The Nasdaq Stock Market LLC. If the Preferred Stock were to fully convert (including if the conversion price is reduced to the Floor Price), the Company would issue up to 4,779,333 shares of Common Stock.

 

Limitations on Conversion

 

A holder of the Preferred Stock is prohibited from converting shares of Preferred Stock into shares of Common Stock (the “Beneficial Ownership Limitation”) if, as a result of such conversion, such holder, together with its affiliates, would beneficially own in excess of 4.99% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion, subject to adjustment by the holder to up to 19.99% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion upon 61 days’ prior notice.

  

Dividend Terms

 

Dividends accrue on the Preferred Stock at the rate of 8% per annum, compounding quarterly and, if dividends are not paid in cash, the rate increases to 9% per annum. Dividends may be paid in cash from any funds legally available for the declaration of dividends, in additional shares of Preferred Stock, or by increasing the stated value on the Corporation’s books by the amount of the dividend. Dividends are payable as and when the Board of Directors of the Company may determine, upon liquidation and upon occurrence of a Fundamental Transaction (as such term is defined in the Certificate of Designation).

 

1

 

Rank; Liquidation Preference

 

The Preferred Stock ranks prior in and preference to the Common Stock and pari passu (unless otherwise agreed by holders of at least a majority of the outstanding shares of Preferred Stock) with the Company’s Series B Non-Voting Convertible Preferred Stock and any other series of the Corporation’s preferred stock with respect to payment of dividends and the consummation of any redemption. In the event of the liquidation, dissolution or winding-up of the Company (a “Liquidation”), whether voluntarily or involuntarily, the holders of Preferred Stock will be entitled to receive an amount in cash per share of Preferred Stock equal to 150% of the stated value of such shares prior and in preference to the Common Stock and pari passu with the Company’s Series B Non-Voting Convertible Preferred Stock and any other series of preferred stock.

 

Voting Rights

 

Holders of the Preferred Stock are entitled to vote on an as-converted basis alongside holders of Common Stock as a single class, subject to the Beneficial Ownership Limitation. In addition, as long as any shares of Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of Preferred Stock, alter or change adversely the powers, preferences or rights given to the Preferred Stock or alter or amend the Certificate of Designation, authorize or create any class of stock ranking as to dividends, redemption or distribution of assets upon a liquidation senior to, or otherwise pari passu with, the Preferred Stock, amend its certificate of incorporation in any manner that adversely affects any rights of the holders of Preferred Stock, increase the number of authorized shares of Preferred Stock, declare dividends on or redeem junior securities while accrued dividends remain unpaid, enter into affiliate transactions exceeding $1 million without disinterested director approval or enter into any agreement with respect to any of the foregoing.

 

Redemption

 

Holders of the Preferred Stock are entitled to redeem their shares after three years at a redemption price equal to 110% of the stated value of such shares, plus accrued and unpaid dividends. The Company may redeem all or part of the Preferred Shares at any time after the 24-month anniversary of the issuance date by giving the holder at least 30 days’ written notice. The buyback price depends on timing: 115% of stated value if redeemed between the 24-month and 36-month anniversaries, and 110% of stated value after the 36-month anniversary, in each case plus accrued and unpaid dividends.

 

In addition, in the event the Company enters into a transaction which results in a change of control of 50% or more of its then outstanding shares of Common Stock on a fully diluted basis, sells substantially all its assets, or effects a “going-private” transaction such that it is no longer a publicly reporting company, a holder of Preferred Stock will be entitled to redeem its shares at a redemption price equal to the greater of (i) the stated value of such shares, plus all accrued and unpaid dividends or (ii) the as-converted market value of the shares of Common Stock issuable upon conversion of the shares of Preferred Stock based on the average of the last closing price of the Common Stock during the five trading days preceding the date of the holder’s redemption notice.

 

The Warrant

 

Exercise Terms

 

The Warrants shall be immediately exercisable upon issuance, have a term of five years from the date of issuance, and be exercisable for shares of Common Stock at the Exercise Price of $2.895 per share; provided that the exercise price and number of shares of Common Stock issuable upon exercise of the Warrants are subject to customary adjustments pursuant to stock dividends, stock splits or similar events.

  

Fundamental Transaction

 

If a Fundamental Transaction (as such term is defined in the Warrant) occurs, then the successor entity will succeed to, and be substituted for the Company, and may exercise every right and power that the Company may exercise and will assume all of the Company’s obligations under the Warrants with the same effect as if such successor entity had been named in the Warrant itself. If holders of the Common Stock are given a choice as to the securities, cash or property to be received in a Fundamental Transaction, then the holder shall be given the same choice as to the consideration it receives upon any exercise of the Warrant following such Fundamental Transaction.

 

Rights of Holder

 

Except as otherwise provided in the Warrants or by virtue of such holder’s ownership of shares of Common Stock, the holder of a Warrant does not have the rights or privileges of a holder of the Common Stock, including any voting rights, until the holder exercises the Warrant.

 

2

 

Limitations on Exercise

 

The holder of the Warrant is prohibited from exercising the Warrant for shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own in excess of 4.99%. The holder can elect a 19.99% cap instead, and any increase takes effect only 61 days after notice to the Company. 

 

The Exchange Agreement

 

Pursuant to the Exchange Agreement, on June 11, 2026, the Company issued the Securities and the Outstanding Debt was cancelled. The Exchange Agreement contains customary representations and warranties and agreements by the Company and the Debtholder.

 

In the Exchange Agreement, the Debtholder acknowledged that the shares of Common Stock issuable upon conversion of the Preferred Shares and the exercise of the Warrants are subject to an exchange cap (as defined in the Certificate of Designation and the Warrants, respectively) such that the Company will not issue shares of Common Stock upon a conversion of the Preferred Shares or the exercise of the Warrants if the issuance of such shares of Common Stock would exceed the aggregate number of shares of Common Stock which the Company may issue without breaching its obligations under the rules or regulations of Nasdaq.

 

In the event the Company’s Common Stock is delisted from Nasdaq for 30 or more consecutive trading days without relisting on an approved exchange, the Exchange Agreement provides that the Debtholder may elect to, by written notice to the Company, exchange the Preferred Shares for an unsecured promissory note of the Company bearing 10% annual interest with a 24-month maturity.

 

The foregoing descriptions of the Certificate of Designation, Exchange Agreement and the Warrants are qualified in their entirety by reference to the full text of such agreements, copies of which are attached hereto as Exhibit 3.1, 10.1 and 4.1, respectively, and each of which is incorporated herein in its entirety by reference. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.

 

Item 3.02. Unregistered Sales of Equity Securities.

 

The information set forth under Item 1.01 above of this Current Report on Form 8-K is incorporated by reference in this Item 3.02. When issuing the shares of Preferred Stock and the Warrant pursuant to the Exchange Agreement in exchange for the cancellation of the Note, the Company relied upon the exemption from the registration requirements of the Securities Act available under Section 3(a)(9) promulgated thereunder due to the fact that Company was the same issuer of the Note, the Debtholder did not pay any additional consideration besides cancelling the outstanding Note, the exchange was made with a current Company investor and the Company did not pay any commission or remuneration for the solicitation of the exchange. The shares of the Company’s Common Stock to be issued upon conversion of the Preferred Stock, to the extent issued, will also be issued pursuant to an exemption from the registration requirements of the Securities Act available under Section 3(a)(9) promulgated thereunder. The shares of Preferred Stock, the Warrant and the shares of Common Stock that may be issued upon conversion of the Preferred Stock have not been registered under the Securities Act and may not be offered or sold in the United States in the absence of an effective registration statement or exemption from the registration requirements.

 

The shares of the Company’s Common Stock to be issued upon exercise of the Warrant will be issued and sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder. In the Exchange Agreement, the Debtholder represented that it is an “accredited investor” as defined in Regulation D of the Securities Act.

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On June 12, 2026, the Company held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved an amendment (the “Plan Amendment”) to the Company’s 2023 Incentive Compensation Plan, as amended (the “2023 Plan”), to (i) increase the number of shares of Common Stock authorized for issuance under the 2023 Plan from 138,861 shares to 520,000 shares, and (ii) increase the total number of shares of Common Stock with respect to which awards may be granted to any non-employee director in his or her capacity as a non-employee director in any single calendar year by 72,500 shares to 75,000 shares. A summary of the material terms of the 2023 Plan is incorporated herein by reference from pages 54-61 of the Company’s definitive proxy statement on Schedule 14A for the Annual Meeting, as filed with the Securities and Exchange Commission (the “SEC”) on May 15, 2026 (the “Proxy Statement”). A copy of the Plan Amendment is attached hereto as Exhibit 10.1 and is incorporated by reference herein.

 

3

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

Certificate of Designation

 

The matters described in Item 1.01 of this Current Report on Form 8-K related to the Preferred Stock and the Certificate of Designation are incorporated herein by reference. A copy of the Certificate of Designation is attached hereto as Exhibit 3.1 and incorporated herein by reference.

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

At the Annual Meeting, the stockholders voted on eight proposals, each of which is listed below and described in more detail in the Company’s Proxy Statement. With respect to each proposal, holders of the Company’s Common Stock were entitled to cast one vote per share of Common Stock held as of the close of business on the record date of April 13, 2026 (the “Record Date”). On the Record Date there were 2,499,293 shares of the Company’s Common Stock issued and outstanding and entitled to vote at the Annual Meeting.

 

The following are the final results of voting on each of the proposals presented at the Annual Meeting:

 

Proposal 1 — Election of Class III Directors Proposal

 

The stockholders elected each of James D. Burnham and Peter G. DeMaria to serve as a Class III director until the 2029 Annual Meeting of Stockholders, based on the votes below:

 

   For  Withheld  Broker
Non-Votes
James D. Burnham  556,017  15,984  427,279
Peter G. DeMaria  555,947  16,054  427,279

 

Proposal 2 — Auditor Ratification Proposal

 

The stockholders ratified the appointment of M&K CPAS PLLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, based on the votes below:

 

Votes For   Votes Against   Abstentions   Broker Non-Votes
837,316   152,570   9,393   -

 

Proposal 3 — Additional February Warrant Exercise Proposal

 

The stockholders approved, pursuant to Nasdaq Rule 5635(d), the issuance of up to 862,335 shares of the Company’s Common Stock upon the exercise of certain warrants which were issued to investors in connection with the Company’s private placement offering that closed on February 17, 2026, based on the votes listed below:

 

Votes For   Votes Against   Abstentions   Broker Non-Votes
546,161   22,436   3,404   427,279

 

Proposal 4 — Initial April Note and Second April Note Conversion Proposal

 

The stockholders approved, pursuant to Nasdaq Rule 5635(d), of the issuance of up to 26,779,029 shares of the Company’s Common Stock upon the conversion of senior convertible notes (collectively, the “April Notes”) in the aggregate principal amount of up to $13.0 million (assuming such April Notes accrue interest at 10% for 12 months and that the conversion price is reduced to the floor price), which April Notes have been, or may in the future be, issued to investors pursuant to a Securities Purchase Agreement dated April 30, 2026 (the “April Purchase Agreement”), based on the votes below:

 

For   Against   Abstain   Broker Non-Votes
542,888   26,661   2,452   427,279

 

4

 

Proposal 5Additional April Note Conversion Proposal

 

The stockholders approved, pursuant to Nasdaq Rule 5635(d), of the issuance of up to an additional 179,213,485 shares of the Company’s Common Stock upon the conversion of additional April Notes in the aggregate principal amount of up to $87.0 million (collectively, the “Additional April Notes”) (assuming such Additional April Notes accrue interest at 10% for 12 months and that the conversion price is reduced to the floor price), which Additional April Notes may in the future be issued to investors pursuant to the April Purchase Agreement, based on the votes below:

 

For   Against   Abstain   Broker Non-Votes
539,231   30,318   2,452   427,279

 

Proposal 6 - Reverse Stock Split Proposal

 

The stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to, at the discretion of the Board, effect a reverse stock split with respect to the Company’s issued and outstanding Common Stock, at a ratio of 1-for-5 to 1-for-10 (the “Range”), with the final ratio within such Range to be determined at the discretion of the Board and included in a public announcement, based on the votes below:

 

For   Against   Abstain   Broker Non-Votes
801,362   193,585   4,333   0

 

 Proposal 72023 Plan Amendment Proposal

 

The stockholders approved an amendment to the Company’s 2023 Plan to (i) increase the number of shares of Common Stock authorized for issuance under the 2023 Plan from 138,861 shares to 520,000 shares, and (ii) increase the total number of shares of Common Stock with respect to which awards may be granted to any non-employee director in his or her capacity as a non-employee director in any single calendar year by 72,500 shares to 75,000 shares, based on the votes below:

 

For   Against   Abstain   Broker Non-Votes
541,578   28,484   1,939   427,279

 

Proposal 8– Adjournment Proposal

 

The stockholders approved an adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Additional February Warrant Exercise Proposal, the Initial April Note and Second April Note Conversion Proposal, the Additional April Note Conversion Proposal, the Reverse Stock Split Proposal or the 2023 Plan Amendment Proposal, based on the votes below. However, the Company elected not to adjourn the Annual Meeting, as such an adjournment was not necessary in light of the approval of the Additional February Warrant Exercise Proposal, the Initial April Note and Second April Note Conversion Proposal, the Additional April Note Conversion Proposal, the Reverse Stock Split Proposal and the 2023 Plan Amendment Proposal at the Annual Meeting.

 

For   Against   Abstain   Broker Non-Votes
803,648   179,085   16,546   0

 

Item 7.01. Regulation FD Disclosure.

 

On June 11, 2026, the Company issued a press release (the “Press Release”) announcing the Exchange. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

 

The information in this Item 7.01 and Exhibit 99.1 attached hereto are furnished and shall not be deemed to be “filed” with the SEC for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

5

 

Item 9.01 Financial Statements and Exhibits.

 

The following exhibits are filed or furnished, as applicable, with this Report:

 

(d) Exhibits

 

Exhibit
Number
  Exhibit Description
3.1   Certificate of Designation of Series C Convertible Preferred Stock
4.1   Warrant, dated June 11, 2026
10.1   Exchange Agreement, dated June 11, 2026
10.2   Amendment No. 2 to the Safe and Green Development 2023 Incentive Compensation Plan
99.1   Press Release, dated June 11, 2026
104   Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)

 

6

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: June 15, 2026

RENX ENTERPISES CORP.

   
  By: /s/ Nicolai Brune
  Name: Nicolai Brune
  Title: Chief Financial Officer

 

7

 

Exhibit 99.1

 

RenX Eliminates $7 Million of Debt in Equity Conversion

 

MIAMI, FL, June 11, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corp. (NASDAQ: RENX) (“RenX” or the “Company”) today announced a debt-to-equity conversion that reduces leverage and strengthens its balance sheet. The transaction is part of a deliberate effort to clean up the Company’s capital structure and enhance the financial profile of the business as it prepares for its next phase of growth.

 

RenX converted approximately $7 million of debt into preferred equity, removing that debt from its balance sheet. The debt was held by Company insiders, who exchanged it for preferred stock rather than common stock, so the conversion does not result in any immediate dilution to common shareholders. The preferred converts into common stock only at $2.895 per share, and the insiders’ decision to convert at a premium to the market reflects confidence in RenX’s future growth plans.

 

Reducing leverage in this way lowers the Company’s ongoing cash obligations and strengthens the balance sheet metrics that lenders and investors weigh, all without any use of cash. A cleaner capital structure improves the Company’s financial profile and positions RenX to pursue growth capital with greater flexibility, free from the constraints that higher debt places on a company’s strategic options.

 

This balance sheet work is paired directly with the Company’s growth strategy. By strengthening its financial foundation now, RenX intends to support continued investment across its environmental processing operations and logistics platform, aligning a healthier capital structure with its plans to scale the business.

 

“We are deliberately cleaning up our balance sheet and reducing leverage to strengthen the financial profile of the business,” said David Villarreal, Chief Executive Officer of RenX Enterprises Corp. “Having insiders convert this debt into preferred equity at a premium to the market, with no immediate dilution to our common shareholders, reflects real confidence in where we are taking the business and pairs directly with our plans for growth. A stronger foundation gives us the flexibility to keep investing behind our environmental solutions and logistics platform as we scale.”

 

The preferred stock, and the common stock issuable upon its conversion, were issued in a private transaction exempt from registration under the Securities Act of 1933, as amended, and are restricted securities. Because the holders are affiliates of the Company, any resale of these securities is subject to the volume, holding period, manner-of-sale, current public information, and other limitations applicable to affiliates under Rule 144.

 

Additional terms of the transaction will be included in a Current Report on Form 8-K to be filed by the Company with the Securities and Exchange Commission.

 

About RenX Enterprises Corp.

 

RenX Enterprises Corp. is a technology-driven environmental processing and sustainable materials company focused on producing value-added compost, engineered soils, and specialty growing media for agricultural, commercial, and consumer end markets. The Company’s platform is designed to be differentiated by its use of advanced milling and material-processing technology, including a planned deployment of a licensed Microtec system, to precisely size, refine, and condition organic inputs into consistent, high-performance soil substrates. This technology-enabled approach allows RenX to move beyond traditional waste-to-value operations and manufacture engineered growing media with repeatable quality and defined specifications.

 

 

 

RenX’s core operations are anchored by a permitted 80+ acre organics processing facility in Myakka City, Florida. At this facility, the Company integrates organics processing, advanced milling, blending, and in-house logistics to support the localized production of proprietary soil substrates and potting media. The Company’s wholly owned subsidiary, Zimmer Equipment Inc., provides commercial hauling and heavy equipment logistics services, supporting both internal material movement and third-party industrial freight customers. The Company believes that by optimizing products for regional feedstocks and customer requirements, it can shorten supply chains, enhance quality control, and improve unit economics while serving higher-value end markets. The Company also owns a portfolio of legacy real estate assets, which it intends to monetize to fund its core technology-driven environmental processing platform.

 

Forward-Looking Statements

 

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are or may be deemed to be forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates” and similar expressions and include, among others, statements regarding cleaning up the Company’s capital structure and enhancing the financial profile of the business as it prepares for its next phase of growth, the confidence of insiders in the Company’s growth plans, positioning RenX to pursue growth capital with greater flexibility, free from the constraints that higher debt places on the Company’s strategic options, supporting continued investment across the Company’s environmental processing operations and logistics platform, aligning a healthier capital structure with the Company’s  plans to scale the business, having the flexibility to keep investing behind the Company’s environmental solutions and logistics platform as it scales, differentiating the Company’s platform by using advanced milling and material-processing technology, including a planned deployment of a licensed Microtec system, to precisely size, refine, and condition organic inputs into consistent, high-performance soil substrates, moving beyond traditional waste-to-value operations and manufacture engineered growing media with repeatable quality and defined specification, shortening supply chains, enhancing quality control, and improving unit economics while serving higher-value end markets by optimizing products for regional feedstocks and customer requirements, it can shorten supply chains, enhance quality control, and improve unit economics while serving higher-value end markets, monetizing the Company’s portfolio legacy real estate assets to fund its core technology-driven environmental processing platform. Forward-looking statements are based on assumptions and analyses made by management in light of historical experience, current conditions, and expected future developments. These forward-looking statements are based on certain assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions, and expected future developments, as well as other factors we believe are appropriate in the circumstances. Important factors that could cause actual results to differ materially from current expectations include the Company’s ability to implement its growth plans, the Company’s ability to deploy and commission the Microtec system on the timeline anticipated, the Company’s ability to maintain adequate liquidity and working capital, the Company’s ability to maintain its Nasdaq listing, the potential future dilution to common stockholders upon conversion of the preferred stock into common stock and the accrual of dividends payable in additional shares, the Company’s reliance on third-party technologies, partners, and customers; the availability and cost of feedstock and other inputs, market acceptance of engineered growing media and bulk materials products, general economic and market conditions, including those resulting from geopolitical events, and other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and its subsequent filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

 

For Media and IR inquiries please contact:

 

Nicolai Ayrton Brune

Chief Financial Officer

RenX Enterprises Corp.info@renxent.com

 

 

 

 

 

FAQ

What debt-to-equity exchange did RenX (RENX) complete in June 2026?

RenX exchanged $7,169,072.79 of principal and accrued interest on a related-party promissory note for 7,169 shares of Series C Convertible Preferred Stock and a warrant for 619,084 common shares, cancelling the outstanding debt and removing it from the balance sheet.

What are the key terms of RenX’s new Series C Convertible Preferred Stock?

Each share has $0.001 par value, $1,000 stated value, an 8% dividend compounding quarterly (9% if not paid in cash), a 150% liquidation preference, optional conversion at $2.895 per share with a $1.50 floor, and full-ratchet anti-dilution subject to that floor.

How much potential dilution could arise from RenX’s new preferred stock and notes approvals?

The Series C Preferred could convert into up to 4,779,333 common shares at the floor price, plus 619,084 warrant shares. Separately, stockholders approved up to 26,779,029 shares from April Notes and 179,213,485 shares from Additional April Notes, significantly exceeding 2,499,293 shares outstanding on the record date.

What ownership limits apply to RenX’s preferred stock and warrants?

Holders cannot convert or exercise if they would exceed 4.99% beneficial ownership of common stock, but may opt to increase this cap up to 19.99% with 61 days’ prior notice. Similar 4.99%–19.99% limits apply to warrant exercises, constraining individual holder concentration.

What equity plan changes did RenX (RENX) stockholders approve at the 2026 meeting?

Stockholders approved amending the 2023 Incentive Compensation Plan to raise authorized shares from 138,861 to 520,000 and to increase the maximum annual non-employee director award capacity by 72,500 shares to 75,000 shares, expanding capacity for future equity-based compensation grants.

Did RenX stockholders authorize a reverse stock split in 2026?

Yes. Stockholders approved an amendment allowing the board, at its discretion, to effect a reverse stock split of issued and outstanding common stock at a ratio between 1-for-5 and 1-for-10, with the final ratio to be selected and announced publicly by the board.

Filing Exhibits & Attachments

8 documents